These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 21397587

  • 1. Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells.
    Reed S, Li H, Li C, Lin J.
    Biochem Biophys Res Commun; 2011 Apr 15; 407(3):450-5. PubMed ID: 21397587
    [Abstract] [Full Text] [Related]

  • 2. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
    Wei CC, Ball S, Lin L, Liu A, Fuchs JR, Li PK, Li C, Lin J.
    Int J Oncol; 2011 Jan 15; 38(1):279-85. PubMed ID: 21109950
    [Abstract] [Full Text] [Related]

  • 3. Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines.
    Liu DB, Long GX, Mei Q, Wang JF, Hu GY, Gan L, Li WW, Sun W, Liu SF, Jiang JZ, Hu GQ.
    Pharmazie; 2014 May 15; 69(5):358-61. PubMed ID: 24855827
    [Abstract] [Full Text] [Related]

  • 4. Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells.
    Liu A, Liu Y, Xu Z, Yu W, Wang H, Li C, Lin J.
    Cancer Sci; 2011 Jul 15; 102(7):1381-7. PubMed ID: 21435102
    [Abstract] [Full Text] [Related]

  • 5. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
    Liu Y, Liu A, Li H, Li C, Lin J.
    Cancer Prev Res (Phila); 2011 Aug 15; 4(8):1296-305. PubMed ID: 21490132
    [Abstract] [Full Text] [Related]

  • 6. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA, Nikitakis NG, Sauk JJ.
    Int J Oral Maxillofac Surg; 2007 Jul 15; 36(7):632-9. PubMed ID: 17566705
    [Abstract] [Full Text] [Related]

  • 7. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S.
    Clin Cancer Res; 2005 Nov 01; 11(21):7674-82. PubMed ID: 16278387
    [Abstract] [Full Text] [Related]

  • 8. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
    Kwak YE, Jeon NK, Kim J, Lee EJ.
    Ann N Y Acad Sci; 2007 Jan 01; 1095():99-112. PubMed ID: 17404023
    [Abstract] [Full Text] [Related]

  • 9. Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.
    Yang MY, Lee HT, Chen CM, Shen CC, Ma HI.
    Int J Mol Sci; 2014 Jun 18; 15(6):11013-29. PubMed ID: 24945311
    [Abstract] [Full Text] [Related]

  • 10. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
    Liu Y, Liu A, Xu Z, Yu W, Wang H, Li C, Lin J.
    Apoptosis; 2011 May 18; 16(5):502-10. PubMed ID: 21311975
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines.
    Park SW, Kim HS, Hah JW, Jeong WJ, Kim KH, Sung MW.
    Anticancer Drugs; 2010 Oct 18; 21(9):823-30. PubMed ID: 20717005
    [Abstract] [Full Text] [Related]

  • 12. OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
    Zhang S, Suvannasankha A, Crean CD, White VL, Johnson A, Chen CS, Farag SS.
    Clin Cancer Res; 2007 Aug 15; 13(16):4750-8. PubMed ID: 17699852
    [Abstract] [Full Text] [Related]

  • 13. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R, Kumar V, Lohite K, Karnik S, Kundu GC.
    Carcinogenesis; 2010 Feb 15; 31(2):192-200. PubMed ID: 19926637
    [Abstract] [Full Text] [Related]

  • 14. [Inhibitory effects of COX-2 inhibitor on migration of human tongue squamous cell carcinoma Tca8113 cells].
    Huo QJ, Li WZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov 15; 29(11):2194-6. PubMed ID: 19923064
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y, Liu J, Wang LZ, Zhang WY, Zhu XZ.
    Acta Pharmacol Sin; 2005 Aug 15; 26(8):952-8. PubMed ID: 16038627
    [Abstract] [Full Text] [Related]

  • 16. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 17. Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells.
    Chen CL, Loy A, Cen L, Chan C, Hsieh FC, Cheng G, Wu B, Qualman SJ, Kunisada K, Yamauchi-Takihara K, Lin J.
    BMC Cancer; 2007 Jun 28; 7():111. PubMed ID: 17598902
    [Abstract] [Full Text] [Related]

  • 18. Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
    Kardosh A, Soriano N, Pyrko P, Liu YT, Jabbour M, Hofman FM, Schönthal AH.
    J Biomed Sci; 2007 Sep 28; 14(5):647-62. PubMed ID: 17440835
    [Abstract] [Full Text] [Related]

  • 19. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B, Shi ZL, Feng J, Tao HM.
    Cell Biol Int; 2008 May 28; 32(5):494-501. PubMed ID: 18078766
    [Abstract] [Full Text] [Related]

  • 20. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
    Arunasree KM, Roy KR, Anilkumar K, Aparna A, Reddy GV, Reddanna P.
    Leuk Res; 2008 Jun 28; 32(6):855-64. PubMed ID: 18083230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.